clinical sciences building
Clinical Sciences Building with CBPG laboratories
 
   
   May, 2003
   CBPG receives major
   grant from the American
   Chemical Council for the
   study of human exposure
   to the carcinogen
   ethylene oxide.
   more
The Cancer Biomarkers and Prevention Group was formed in 2001 by researchers at Leicester University with a major interest in chemoprevention. The group at present comprises some forty research workers including the following principal investigators and their associates:
 
 
 
Dept. of Oncology:
 
   
   Sept, 2002
   CBPG receives major 
   research grant for the
   preclinical and clinical
   evaluation of resveratrol,
   a natural compound
   found in red wine.
   more
Prof. W.P. Steward
Prof. A.J. Gescher
Dr. T. Marczylo (Lecturer)
Dr. R. Sharma (Hon. Lecturer)
 
Dept. of Biochemistry:
 
Prof. P.B. Farmer
Dr. M.M. Manson (Hon. Reader)
Dr. C.F. Harrington
 
Biocentre
Biocentre with CBPG laboratories
 
The group is excellently equipped for work involving analytical chemistry, molecular epidemiology, cellular and molecular biology, drug metabolism, in vivo-models of carcinogenesis and small scale clinical trials. The budget of the combined group exceeds 1.5 million pounds per annum, with sponsorship mainly by the UK Medical Research Council, US National Cancer Institute, European Union, Cancer Research UK, Association for international Cancer Research and the pharmaceutical industry.

 

 
  | The  GroupOncology in Leicester  | Why Chemoprevention  |  Mechanisms  Section
| Biomonitoring Section  |  Pharmacology Section  |  Achievements  | News |  References  |  Contacts